Copyright: © 2021 Elsevier Ltd. All rights reserved. SGLT2 inhibitors and GLP-1 receptor agonists are used in patients with type 2 diabetes as glucose lowering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback